Lucy Day
Director of Finance/CFO at AN2 THERAPEUTICS, INC.
Net worth: 69 830 $ as of 2024-04-29
Lucy Day active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Director of Finance/CFO | 2019-10-31 | - |
Career history of Lucy Day
Former positions of Lucy Day
| Companies | Position | Start | End |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Director of Finance/CFO | 2002-02-28 | 2016-07-31 |
| Human Resources Officer | 2002-02-28 | 2016-07-31 | |
| Centaur Pharmaceuticals, Inc. | Director of Finance/CFO | 1994-01-31 | 2001-12-31 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 1989-12-31 | 1993-12-31 |
Training of Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Director of Finance/CFO | 3 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| Private companies | 2 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
- Stock Market
- Insiders
- Lucy Day
- Experience
